Tag: NTI drugs

3, July, 2026

FDA Bioequivalence Standards for NTI Drugs: Special Requirements Explained

Explore the FDA's stricter bioequivalence standards for Narrow Therapeutic Index (NTI) drugs. Learn about the 90-111% limits, tighter quality assays, and why these special requirements matter for patient safety.